Does METRONIDAZOLE Cause Agranulocytosis? 127 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Agranulocytosis have been filed in association with METRONIDAZOLE (metronidazole). This represents 0.6% of all adverse event reports for METRONIDAZOLE.
127
Reports of Agranulocytosis with METRONIDAZOLE
0.6%
of all METRONIDAZOLE reports
1
Deaths
91
Hospitalizations
How Dangerous Is Agranulocytosis From METRONIDAZOLE?
Of the 127 reports, 1 (0.8%) resulted in death, 91 (71.7%) required hospitalization, and 35 (27.6%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METRONIDAZOLE. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does METRONIDAZOLE Cause?
Drug ineffective (3,336)
Nausea (1,944)
Off label use (1,507)
Headache (1,167)
Vomiting (1,160)
Abdominal pain (1,076)
Pyrexia (1,048)
Diarrhoea (1,041)
Drug hypersensitivity (994)
Dizziness (900)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which METRONIDAZOLE Alternatives Have Lower Agranulocytosis Risk?
METRONIDAZOLE vs METRONIDAZOLE\METRONIDAZOLE
METRONIDAZOLE vs METYRAPONE
METRONIDAZOLE vs MEXILETINE
METRONIDAZOLE vs MIANSERIN
METRONIDAZOLE vs MICAFUNGIN